Cytolytic activity score (CYT), defined as the sum of expression of granzyme A (GZMA) and perforin (PRF1), was used to evaluate overall anti-cancer immune cell killing in the tumor microenvironment (25594174). This evidence concerns the gene GZMA and cancer.